SALT LAKE CITY — Schiff Nutrition on Thursday named three new members to its recently established scientific advisory board: Dale Bredesen, Michael Fischbach and Charles Serhan.
"These three additions strengthen and diversify the expertise from which to draw as we pursue new product development," stated Tarang Amin, Schiff president and CEO. "We look forward to the guidance of Dr. Bredesen in aging and age-associated diseases, Dr. Fischbach in probiotics and Dr. Serhan in inflammation. This is all complemented by Dr. Carmona’s background as one of the world’s leading experts in public health.”
Richard Carmona, 17th surgeon general of the United States, currently serves as chair of the scientific advisory board.
Bredesen is professor and president of the Buck Institute for Age Research, an independent research institute focused on aging and age-associated disease and adjunct professor of the Department of Neurology at University of California - San Francisco. Bredesen is a member of the National Advisory Council on Aging, the Society for Neuroscience, and the American Society for Biochemistry and Molecular Biology. He has co-authored more than 180 scientific papers and three books. He received his undergraduate degree from Caltech and his M.D. from Duke University School of Medicine.
Fischbach is an assistant professor in the Department of Bioengineering and Therapeutic Sciences at UCSF and a member of the California Institute of Quantitative Biosciences. Fischbach is a recipient of the NIH Director's New Innovator Award, a Fellowship for Science and Engineering from the David and Lucille Packard Foundation, a Medical Research award from the W.M. Keck Foundation and the Young Investigator Grant for Probiotics Research from the Global Probiotics Council. Fischbach worked at Harvard University and spent two years as an independent fellow at Massachusetts General Hospital. Fischbach received his Ph.D. in chemistry from Harvard University.
Serhan is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School, a professor in the Department of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine and an affiliate faculty member of MIT. Serhan was appointed to the Harvard Faculty in 1986 and has served as senior biochemist in medicine at Brigham and Women’s Hospital since 1992. An author of 346 publications, he has received a number of awards and honors, including a MERIT Award from the National Institute of General Medical Sciences and an honorary degree from Harvard University. Serhan received degrees in biochemistry from Stony Brook University, experimental pathology and medical sciences at the New York University School of Medicine, as well as post-doctoral training in physiological chemistry at the Karolinska Institute Medical University in Stockholm, Sweden.